Skip to main content
main-content

Zeitschrift

Targeted Oncology

Targeted Oncology 1/2019

Ausgabe 1/2019

Inhaltsverzeichnis ( 12 Artikel )

22.08.2018 | Review Article | Ausgabe 1/2019 Open Access

Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer

Sarah Sammons, Noah S. Kornblum, Kimberly L. Blackwell

08.12.2018 | Correction | Ausgabe 1/2019 Open Access

Correction to: Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer

Sarah Sammons, Noah S. Kornblum, Kimberly L. Blackwell

29.01.2019 | Review Article | Ausgabe 1/2019

The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG)

Albert Font, Raquel Luque, José Carlos Villa, Montse Domenech, Sergio Vázquez, Enrique Gallardo, Juan Antonio Virizuela, Carmen Beato, Rafael Morales-Barrera, Antoni Gelabert, Sonia Maciá, Javier Puente, Gustavo Rubio, Xavier Maldonado, Begoña Perez-Valderrama, Alvaro Pinto, Ovidio Fernández Calvo, Enrique Grande, Javier Garde-Noguera, Eva Fernández-Parra, José Ángel Arranz

03.01.2019 | Original Research Article | Ausgabe 1/2019

Phase 2 Multicenter Single-Arm Study of Second-Line Axitinib in Favorable Risk Patients with Metastatic Renal Cell Carcinoma: FavorAx

Ilya Tsimafeyeu, Pavel Borisov, Ahmed Abdelgafur, Roman Leonenkov, Olga Novikova, Irina Guseva, Marina Demchenkova, Nadezhda Mikhailova, Andrey Semenov, Zakhar Yurmazov, Irina Sivunova, Madina Ramazanova, Sergey Gamayunov, Dmitry Kosov, Gennady Bratslavsky

01.02.2019 | Commentary | Ausgabe 1/2019

BI 853520, a FAK-Simile of Prior FAK Inhibitors?

Rachael Chang Lee, Hui K. Gan

11.02.2019 | Original Research Article | Ausgabe 1/2019 Open Access

Phase I Study of BI 853520, an Inhibitor of Focal Adhesion Kinase, in Patients with Advanced or Metastatic Nonhematologic Malignancies

Maja J. A. de Jonge, Neeltje Steeghs, Martijn P. Lolkema, Sebastien J. Hotte, Hal W. Hirte, Diane A. J. van der Biessen, Albiruni R. Abdul Razak, Filip Y. F. L. De Vos, Remy B. Verheijen, David Schnell, Linda C. Pronk, Monique Jansen, Lillian L. Siu

06.02.2019 | Original Research Article | Ausgabe 1/2019 Open Access

Phase I Study of the Focal Adhesion Kinase Inhibitor BI 853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors

Toshihiko Doi, James Chih-Hsin Yang, Kohei Shitara, Yoichi Naito, Ann-Lii Cheng, Akiko Sarashina, Linda C. Pronk, Yoshito Takeuchi, Chia-Chi Lin

11.02.2019 | Original Research Article | Ausgabe 1/2019 Open Access

Randomized, Open-Label, Crossover Studies Evaluating the Effect of Food and Liquid Formulation on the Pharmacokinetics of the Novel Focal Adhesion Kinase (FAK) Inhibitor BI 853520

Remy B. Verheijen, Diane A. J. van der Biessen, Sebastien J. Hotte, Lillian L. Siu, Anna Spreafico, Maja J. A. de Jonge, Linda C. Pronk, Filip Y. F. L. De Vos, David Schnell, Hal W. Hirte, Neeltje Steeghs, Martijn P. Lolkema

12.12.2018 | Original Research Article | Ausgabe 1/2019 Open Access

Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib

Maximilian J. Hochmair, Anna Buder, Sophia Schwab, Otto C. Burghuber, Helmut Prosch, Wolfgang Hilbe, Agnieszka Cseh, Richard Fritz, Martin Filipits

18.01.2019 | Original Research Article | Ausgabe 1/2019

Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry

Li Chia Chong, Amanda Rose Townsend, Joanne Young, Amitesh Roy, Cynthia Piantadosi, Jennifer E. Hardingham, David Roder, Christos Karapetis, Robert Padbury, Guy Maddern, James Moore, Timothy Jay Price

11.01.2019 | Original Research Article | Ausgabe 1/2019

Development of a Novel EGFR-Targeting Antibody-Drug Conjugate for Pancreatic Cancer Therapy

Zhuanglin Li, Mingxue Wang, Xuejing Yao, Wenting Luo, Yaocheng Qu, Deling Yu, Xue Li, Jianmin Fang, Changjiang Huang

14.02.2019 | Adis Drug Evaluation | Ausgabe 1/2019

Cabozantinib: A Review in Advanced Hepatocellular Carcinoma

Emma D. Deeks

Aktuelle Ausgaben